Meltwind
Investor profile
Venture capital
Deals
14
distinct rounds
Companies
13
backed
Active span
2021–2025
5 yrs
Total round €
€124M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- BGF4
- Cambridge Angels4
- IQ Capital3
- o2h Ventures3
- Calculus Capital2
- Crista Galli Ventures2
- Parkwalk Advisors2
- Playfair Capital2
- 4BIO Capital1
- Agilent Ventures1
- Amadeus Capital Partners1
- Ananda Impact Ventures1
- Ascension Life Fund1
- Ascension Ventures1
- Cambridge Enterprise1
- Cystic Fibrosis Foundation1
- David Cleevely1
- Downing Ventures1
- Dr Jonathan Milner1
- Eli Lilly1
- Eli lilly and company1
- Guinness Ventures1
- Hargreave Hale AIM VCT1
- Heal Capital1
- Illumina Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Inotec Amd | UK | 1 | €31M |
| ViaNautis | UK | 1 | €23M |
| Enhanced Genomics | UK | 1 | €16M |
| Closed Loop Medicine | UK | 1 | €15M |
| NanoSyrinx | UK | 1 | €12M |
| Qureight | UK | 2 | €9.8M |
| Tagomics | UK | 1 | €6.2M |
| Axol Bioscience | UK | 1 | €3.8M |
| Psyomics | UK | 1 | €2.8M |
| Sanome | UK | 1 | €2.3M |
| 52 North Health | UK | 1 | €1.2M |
| Five Alarm Bios | UK | 1 | €568k |
| Scarlet Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Inotec Amd | Series C | €31M | 2024-12 |
| ViaNautis | Series A | €23M | 2023-11 |
| Enhanced Genomics | Series A | €16M | 2025-09 |
| Closed Loop Medicine | Series A | €15M | 2021-11 |
| NanoSyrinx | Other | €12M | 2024-09 |
| Qureight | Series A | €8.0M | 2024-04 |
| Tagomics | Other | €6.2M | 2024-02 |
| Axol Bioscience | Other | €3.8M | 2022-04 |
| Psyomics | Other | €2.8M | 2022-06 |
| Sanome | Other | €2.3M | 2021-09 |